title: Hepatic encephalopathy in the course of anti-HCV therapy with paritaprevir/ritonavir, ombitasvir, dasabuvir and ribavirin.
authors.affiliation: Clinic of Infectious Diseases, University of Bari, Piazza G. Cesare 11, 70124 Bari, Italy. Electronic address: claudia_fabrizio@libero.it.
authors.forename: Claudia
authors.initials: C
authors.lastname: Fabrizio
authors.affiliation: Clinic of Infectious Diseases, University of Bari, Piazza G. Cesare 11, 70124 Bari, Italy.
authors.forename: Annalisa
authors.initials: A
authors.lastname: Saracino
authors.affiliation: Clinic of Infectious Diseases, University of Bari, Piazza G. Cesare 11, 70124 Bari, Italy.
authors.forename: Michele
authors.initials: M
authors.lastname: Milella
authors.affiliation: Clinic of Infectious Diseases, S.G. Moscati Hospital, Taranto, Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Resta
authors.affiliation: Clinic of Infectious Diseases, University of Bari, Piazza G. Cesare 11, 70124 Bari, Italy.
authors.forename: Gioacchino
authors.initials: G
authors.lastname: Angarano
mesh_terms: D000368:Aged; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D005260:Female; D006501:Hepatic Encephalopathy / Q000473:pathology*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D000998:Antiviral Agents